To trace the transfer of EVs from GCB‐resistant to GCB‐sensitive bladder cancer cells, EVs derived from T24GCB and 5637GCB cells were labelled with fluorescently tagged antibodies against CD9, CD63 and CD81, and then applied to T24 and 5637 recipient cells. This evidence concerns the gene CD9 and urinary bladder cancer.